IGF2BP2 and metabolic dysfunction-associated steatotic liver disease: Based on the results, the expression of METTL3, METTL14, WTAP, RBM15, FTO, YTHDC1, YTHDC2, IGF2BP2, HNRNPC, HNRNA2B1, and EIF3H were significantly different between healthy liver and NAFLD with a differential expression profile.